WELL Health Technologies Corp. (TSE:WELL) Receives C$6.96 Consensus Price Target from Analysts

WELL Health Technologies Corp. (TSE:WELL) has been assigned a consensus recommendation of “Moderate Buy” from the six research firms that are currently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is C$6.96.

WELL has been the subject of several analyst reports. CIBC raised their target price on shares of WELL Health Technologies from C$4.75 to C$5.00 in a report on Friday, August 16th. Stifel Nicolaus decreased their price target on WELL Health Technologies from C$11.00 to C$10.00 in a research note on Monday, April 29th.

Insiders Place Their Bets

In related news, Senior Officer Eva Fong sold 10,000 shares of the business’s stock in a transaction that occurred on Friday, July 5th. The stock was sold at an average price of C$4.80, for a total value of C$48,000.00. Insiders own 6.83% of the company’s stock.

WELL Health Technologies Stock Up 2.4 %

TSE WELL opened at C$4.68 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.25 and a debt-to-equity ratio of 41.57. WELL Health Technologies has a 52 week low of C$3.41 and a 52 week high of C$5.05. The firm has a market capitalization of C$1.17 billion, a price-to-earnings ratio of 8.21, a PEG ratio of -1.93 and a beta of 1.21. The company has a fifty day moving average of C$4.64 and a two-hundred day moving average of C$4.09.

About WELL Health Technologies

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.